BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10765916)

  • 1. Report on the Fourth International Workshop on Reactive Arthritis.
    Sieper J; Braun J; Kingsley GH
    Arthritis Rheum; 2000 Apr; 43(4):720-34. PubMed ID: 10765916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic responses in reactive arthritis.
    Kingsley G; Panayi G
    Rheum Dis Clin North Am; 1992 Feb; 18(1):49-66. PubMed ID: 1561409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of reactive arthritis.
    Sieper J
    Curr Rheumatol Rep; 2001 Oct; 3(5):412-8. PubMed ID: 11564373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis.
    Alvarez-Navarro C; Cragnolini JJ; Dos Santos HG; Barnea E; Admon A; Morreale A; López de Castro JA
    J Biol Chem; 2013 Sep; 288(36):25810-25825. PubMed ID: 23867464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27.
    Vähämiko S; Penttinen MA; Granfors K
    Arthritis Res Ther; 2005; 7(4):136-41. PubMed ID: 15987495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
    Appel H; Kuon W; Kuhne M; Wu P; Kuhlmann S; Kollnberger S; Thiel A; Bowness P; Sieper J
    Arthritis Res Ther; 2004; 6(6):R521-34. PubMed ID: 15535830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity.
    Mertz AK; Daser A; Skurnik M; Wiesmüller KH; Braun J; Appel H; Batsford S; Wu P; Distler A; Sieper J
    Mol Med; 1994 Nov; 1(1):44-55. PubMed ID: 8790600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease mechanisms in reactive arthritis.
    Sieper J
    Curr Rheumatol Rep; 2004 Apr; 6(2):110-6. PubMed ID: 15016341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.
    Colmegna I; Cuchacovich R; Espinoza LR
    Clin Microbiol Rev; 2004 Apr; 17(2):348-69. PubMed ID: 15084505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aetiological agents and immune mechanisms in enterogenic reactive arthritis.
    Sieper J; Kingsley GH; Märker-Hermann E
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):105-21. PubMed ID: 8674143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27 and host-pathogen interaction.
    Sahlberg AS; Granfors K; Penttinen MA
    Adv Exp Med Biol; 2009; 649():235-44. PubMed ID: 19731633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of infection in the pathogenesis of spondyloarthropathies with special reference to human leukocyte antigen-B27.
    Penttinen MA; Liu Y; Granfors K
    Curr Rheumatol Rep; 2002 Dec; 4(6):518-24. PubMed ID: 12427368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive arthritis.
    Hannu T
    Best Pract Res Clin Rheumatol; 2011 Jun; 25(3):347-57. PubMed ID: 22100285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27.
    Dulphy N; Peyrat MA; Tieng V; Douay C; Rabian C; Tamouza R; Laoussadi S; Berenbaum F; Chabot A; Bonneville M; Charron D; Toubert A
    J Immunol; 1999 Apr; 162(7):3830-9. PubMed ID: 10201900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives in reactive arthritis.
    Kingsley G; Sieper J
    Immunol Today; 1993 Aug; 14(8):387-91. PubMed ID: 8397777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunogenic HLA-B*27:05 binding peptides of salmonella outer membrane protein in patients with reactive arthritis and undifferentiated spondyloarthropathy.
    Singh AK; Aggarwal A; Chaurasia S; Misra R
    J Rheumatol; 2013 Feb; 40(2):173-85. PubMed ID: 23322470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.
    Garcia Ferrer HR; Azan A; Iraheta I; Von Feldt J; Espinoza LR; Manasson J; Scher JU; Garcia Kutzbach A; Ogdie A
    Clin Rheumatol; 2018 Feb; 37(2):415-422. PubMed ID: 29139030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis.
    Alanärä T; Aittomäki S; Kuuliala K; Kuuliala A; Siitonen S; Leirisalo-Repo M; Repo H
    Scand J Rheumatol; 2012 Aug; 41(4):267-74. PubMed ID: 22651550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentations of chlamydial and non-chlamydial reactive arthritis.
    Ozgül A; Dede I; Taskaynatan MA; Aydogan H; Kalyon TA
    Rheumatol Int; 2006 Aug; 26(10):879-85. PubMed ID: 16432687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry.
    Thiel A; Wu P; Lauster R; Braun J; Radbruch A; Sieper J
    Arthritis Rheum; 2000 Dec; 43(12):2834-42. PubMed ID: 11145043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.